2022 American Transplant Congress Archives - Page 96 of 190

Intrinsic DEPTOR Activity Modulates Treg Subset Differentiation

J. Wedel¹, M. Maslyar¹, B. Alsairafi¹, S. Kong², D. M. Briscoe¹
Invasive Fungal Infections Associated with COVID-19 Infections in Solid Organ Transplant Recipients

R. Alameer, M. Nguyen, P. Samanta
Investigating RNA Interference-Mediated Inhibition of Liver Ischemia Reperfusion Injury During Liver Preservation

J. E. Buchwald¹, D. Echeverria², J. Sousa², N. McHugh², A. Khvorova², P. N. Martins³
Is a Single Dose of Steroids in Adult Living Donor Liver Transplant Safe? – A Cohort Analysis

M. Nunez, C. Praglin, A. M. Torres, E. Agudelo, H. Braun, C. Huang, S. Syed, J. Roberts, G. Roll
Is Abo Incompatible Living Donor Liver Transplantation Really a Good Alternative for Pediatric Recipients?

C. de Magnée¹, L. Brunée¹, R. Tambucci¹, A. Pire¹, I. Scheers², E. Sokal², P. Baldin³, F. Zech⁴, S. Eeckhoudt⁵, R. Reding¹, X. Stephenne²
Is BK After SPK Okay?: Kidney and Pancreas Transplant Outcomes After BK Viremia

G. Dube¹, K. McCune², D. Cohen³, L. Ratner², S. Husain¹
Is Donor Hepatitis C Virus Infection Status Associated with Early Post-Kidney Transplant Failure in the Era of Direct-Acting Antiviral Medications?

S. Sutcliffe¹, S. Chang¹, D. Stewart², M. Ji³, K. Lentine⁴, G. Gupta⁵, T. Alhamad⁶
Is Pathologic AMR Grading Scale Associated with the Presence of Donor-Specific Antibodies?

S. Kim, J. Patel, M. Kittleson, T. Singer-Englar, N. Patel, D. Chang, E. Kransdorf, D. Emerson, J. A. Kobashigawa
Is Remnant Liver Volume Ratio Less Than 30% Still Contraindication to Right Hepatectomy for Living Liver Donors?

J. Kim, D. Choi
Is Repeat Resection for Recurrent Intrahepatic Cholangiocarcinoma Warranted? Outcomes of an International Multicenter Analysis

M. L. Holzner¹, V. Mazzaferro², M. Droz dit Busset², L. Aldrighetti³, F. Ratti³, K. Hasegawa⁴, J. Arita⁴, G. Sapisochin⁵, P. Abreu⁵, W. Schoening⁶, N. Nevermann⁶, M. Schmelzle⁶, J. Pratschke⁶, S. Florman¹, K. Halazun⁷, M. E. Schwartz¹, P. Tabrizian¹